New Grant Aims to Jumpstart Treatment Development for Patients with Rare Pediatric Ependymal Tumors Today, the National Brain Tumor Society (NBTS) announced that Johannes Gojo, MD, PhD, of the Medical University of Vienna (Medizinischen Universität Wien), is the recipient of the first-ever CERN PFA Ependymoma Translational Research Award. Dr. Gojo will lead a renowned, interdisciplinary team of pediatric brain cancer experts on a project titled “Targeting DNA damage response […] February 7, 2024
National Brain Tumor Society Statement on Passing of Bobbi Barrasso, Wife of Senator John Barrasso National Brain Tumor Society is saddened to hear of the passing of Bobbi Barrasso, wife of United States Senator John Barrasso, following treatment for glioblastoma (GBM). Our thoughts, condolences, and wishes for comfort are with Senator Barrasso and all Mrs. Barrasso’s family and loved ones. Mrs. Barrasso had a long and admirable career in public […] January 25, 2024
NBTS Names Dr. Manmeet Ahluwalia Clinical Advisor to its DNA Damage Response Consortium Today, the National Brain Tumor Society (NBTS) announced that Manmeet Ahluwalia, MD, MBA, FASCO, Chief Scientific Officer, Chief of Medical Oncology, Deputy Director, and Fernandez Family Endowed Chair at Miami Cancer Institute, part of Baptist Health South Florida, is joining its DNA Damage Response Consortium as Clinical Advisor. The consortium –– which comprises expert teams […] October 25, 2023
NBTS Urges Congress to Keep Brain Tumor Research and Treatment Development Moving Forward David Arons, JD, president and chief executive officer of the National Brain Tumor Society, today released the following statement about averting a potential government shutdown at the end of the Fiscal Year on Friday, September 29, 2023: For thousands of Americans currently living with a brain tumor, the National Institutes of Health (NIH), through its […] September 26, 2023
New National Brain Tumor Society Program Highlighted by White House Cancer Moonshot Today, the White House Cancer Moonshot announced several important and novel initiatives to advance progress towards ending cancer as we know it. Highlighted in this announcement was NBTS’s commitment, made at the first White House Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) during national Brain Tumor Awareness Month […] September 13, 2023